nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—ADRA1D—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.0262	0.029	CbGpPWpGaD
Xylometazoline—HTR1D—Monoamine GPCRs—DRD2—nicotine dependence	0.023	0.0254	CbGpPWpGaD
Xylometazoline—HTR1B—Monoamine GPCRs—DRD2—nicotine dependence	0.0225	0.0248	CbGpPWpGaD
Xylometazoline—ADRA1B—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.0218	0.0241	CbGpPWpGaD
Xylometazoline—ADRA1D—Monoamine GPCRs—DRD2—nicotine dependence	0.0196	0.0217	CbGpPWpGaD
Xylometazoline—ADRA1A—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.0193	0.0214	CbGpPWpGaD
Xylometazoline—HTR1D—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0193	0.0213	CbGpPWpGaD
Xylometazoline—HTR1B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0189	0.0209	CbGpPWpGaD
Xylometazoline—ADRA2B—Monoamine GPCRs—DRD2—nicotine dependence	0.0177	0.0196	CbGpPWpGaD
Xylometazoline—ADRA2C—Monoamine GPCRs—DRD2—nicotine dependence	0.0166	0.0183	CbGpPWpGaD
Xylometazoline—ADRA1D—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0165	0.0183	CbGpPWpGaD
Xylometazoline—ADRA1B—Monoamine GPCRs—DRD2—nicotine dependence	0.0163	0.018	CbGpPWpGaD
Xylometazoline—HTR1D—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0157	0.0173	CbGpPWpGaD
Xylometazoline—HTR1B—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0153	0.0169	CbGpPWpGaD
Xylometazoline—ADRA2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0149	0.0165	CbGpPWpGaD
Xylometazoline—ADRA1A—Monoamine GPCRs—DRD2—nicotine dependence	0.0145	0.016	CbGpPWpGaD
Xylometazoline—ADRA2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0139	0.0154	CbGpPWpGaD
Xylometazoline—ADRA1B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0137	0.0151	CbGpPWpGaD
Xylometazoline—ADRA2A—Monoamine GPCRs—DRD2—nicotine dependence	0.0135	0.0149	CbGpPWpGaD
Xylometazoline—ADRA1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0122	0.0135	CbGpPWpGaD
Xylometazoline—ADRA2B—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0121	0.0134	CbGpPWpGaD
Xylometazoline—ADRA2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0113	0.0125	CbGpPWpGaD
Xylometazoline—ADRA2C—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0113	0.0125	CbGpPWpGaD
Xylometazoline—HTR1B—cardiovascular system—nicotine dependence	0.0112	0.118	CbGeAlD
Xylometazoline—HTR1D—cardiovascular system—nicotine dependence	0.0109	0.114	CbGeAlD
Xylometazoline—HTR1D—GPCR ligand binding—TAS2R16—nicotine dependence	0.00948	0.0105	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00928	0.0103	CbGpPWpGaD
Xylometazoline—ADRA2A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00918	0.0101	CbGpPWpGaD
Xylometazoline—HTR1B—midbrain—nicotine dependence	0.00876	0.092	CbGeAlD
Xylometazoline—HTR1D—midbrain—nicotine dependence	0.00848	0.0891	CbGeAlD
Xylometazoline—ADRA1A—cardiovascular system—nicotine dependence	0.00834	0.0877	CbGeAlD
Xylometazoline—ADRA1D—GPCR ligand binding—TAS2R16—nicotine dependence	0.00812	0.00897	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00733	0.0081	CbGpPWpGaD
Xylometazoline—ADRA1B—brain—nicotine dependence	0.00729	0.0766	CbGeAlD
Xylometazoline—ADRA1D—brain—nicotine dependence	0.00713	0.0749	CbGeAlD
Xylometazoline—ADRA2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.00684	0.00756	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00674	0.00744	CbGpPWpGaD
Xylometazoline—HTR1D—G alpha (i) signalling events—OPRM1—nicotine dependence	0.0066	0.0073	CbGpPWpGaD
Xylometazoline—HTR1B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00646	0.00714	CbGpPWpGaD
Xylometazoline—ADRA2C—midbrain—nicotine dependence	0.00621	0.0652	CbGeAlD
Xylometazoline—HTR1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00613	0.00677	CbGpPWpGaD
Xylometazoline—HTR1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.006	0.00663	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00598	0.00661	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00556	0.00614	CbGpPWpGaD
Xylometazoline—HTR1B—brain—nicotine dependence	0.0055	0.0578	CbGeAlD
Xylometazoline—HTR1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00536	0.00592	CbGpPWpGaD
Xylometazoline—HTR1D—brain—nicotine dependence	0.00533	0.056	CbGeAlD
Xylometazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00525	0.0058	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00525	0.0058	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00524	0.0058	CbGpPWpGaD
Xylometazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00514	0.00568	CbGpPWpGaD
Xylometazoline—ADRA2B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.0051	0.00564	CbGpPWpGaD
Xylometazoline—ADRA2A—midbrain—nicotine dependence	0.00495	0.0521	CbGeAlD
Xylometazoline—HTR1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.00487	0.00538	CbGpPWpGaD
Xylometazoline—HTR1D—G alpha (i) signalling events—DRD2—nicotine dependence	0.00477	0.00528	CbGpPWpGaD
Xylometazoline—ADRA2C—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00477	0.00527	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00476	0.00527	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00473	0.00523	CbGpPWpGaD
Xylometazoline—HTR1B—G alpha (i) signalling events—DRD2—nicotine dependence	0.00467	0.00517	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00459	0.00507	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00449	0.00497	CbGpPWpGaD
Xylometazoline—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00443	0.0049	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00442	0.00489	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00435	0.00481	CbGpPWpGaD
Xylometazoline—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00434	0.00479	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—FGD1—nicotine dependence	0.00421	0.00465	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.00416	0.0046	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00414	0.00458	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—FGD1—nicotine dependence	0.00412	0.00455	CbGpPWpGaD
Xylometazoline—ADRA1A—brain—nicotine dependence	0.00409	0.043	CbGeAlD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00406	0.00448	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—OPRM1—nicotine dependence	0.004	0.00442	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—OPRM1—nicotine dependence	0.00391	0.00433	CbGpPWpGaD
Xylometazoline—ADRA2C—brain—nicotine dependence	0.0039	0.041	CbGeAlD
Xylometazoline—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00387	0.00428	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00387	0.00427	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00387	0.00427	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—FGD1—nicotine dependence	0.00382	0.00422	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00381	0.00421	CbGpPWpGaD
Xylometazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0038	0.00419	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00379	0.00419	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00379	0.00419	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00376	0.00416	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—FGD1—nicotine dependence	0.00374	0.00413	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00373	0.00412	CbGpPWpGaD
Xylometazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00372	0.00411	CbGpPWpGaD
Xylometazoline—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.00369	0.00408	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—FGD1—nicotine dependence	0.0036	0.00398	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00359	0.00397	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.00351	0.00388	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00346	0.00382	CbGpPWpGaD
Xylometazoline—ADRA2C—G alpha (i) signalling events—DRD2—nicotine dependence	0.00345	0.00381	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00342	0.00378	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—OPRM1—nicotine dependence	0.00342	0.00378	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00338	0.00374	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00331	0.00366	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.00327	0.00361	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00325	0.00359	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00325	0.00359	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0032	0.00353	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00315	0.00348	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00314	0.00347	CbGpPWpGaD
Xylometazoline—ADRA2A—brain—nicotine dependence	0.00311	0.0327	CbGeAlD
Xylometazoline—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.00309	0.00341	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00308	0.0034	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00307	0.00339	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.00304	0.00335	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.00299	0.0033	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.00295	0.00326	CbGpPWpGaD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00293	0.00324	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.00289	0.00319	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.00289	0.00319	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.00287	0.00318	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00285	0.00315	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.00284	0.00314	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.00283	0.00313	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.00281	0.00311	CbGpPWpGaD
Xylometazoline—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.0028	0.00309	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0028	0.00309	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.00276	0.00305	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00274	0.00303	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.00271	0.003	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0027	0.00298	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.00265	0.00293	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0026	0.00287	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.00252	0.00279	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.00247	0.00273	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.00247	0.00272	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.00246	0.00272	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.00241	0.00266	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00239	0.00265	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.00234	0.00259	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.00226	0.0025	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—FGD1—nicotine dependence	0.00226	0.00249	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.00224	0.00247	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	0.00223	0.00247	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00222	0.00246	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.00222	0.00245	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.00221	0.00244	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—FGD1—nicotine dependence	0.00221	0.00244	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	0.00209	0.00231	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	0.00207	0.00229	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.00205	0.00227	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	0.00205	0.00227	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.00204	0.00226	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	0.00201	0.00222	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	0.00199	0.0022	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	0.00195	0.00216	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.00193	0.00214	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	0.00193	0.00213	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.00182	0.00202	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.00181	0.002	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	0.00176	0.00194	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.00175	0.00193	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	0.00174	0.00193	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	0.00171	0.00188	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.00169	0.00187	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.00169	0.00186	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	0.00163	0.00181	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.00163	0.0018	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	0.00163	0.0018	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.0016	0.00177	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	0.0016	0.00177	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	0.0016	0.00177	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CYP2A7—nicotine dependence	0.0016	0.00177	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	0.00159	0.00175	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	0.00154	0.0017	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	0.00148	0.00164	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	0.00148	0.00164	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	0.00146	0.00161	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	0.00145	0.00161	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	0.00144	0.00159	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.00143	0.00158	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	0.00142	0.00157	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	0.00142	0.00156	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—WASF2—nicotine dependence	0.0014	0.00155	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	0.0014	0.00154	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—WASF2—nicotine dependence	0.00137	0.00152	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—WASF1—nicotine dependence	0.00135	0.00149	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.00132	0.00146	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	0.00132	0.00146	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—WASF1—nicotine dependence	0.00132	0.00146	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CYP2A7—nicotine dependence	0.0013	0.00144	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	0.00129	0.00143	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	0.00127	0.0014	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	0.00126	0.00139	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	0.00126	0.00139	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	0.00121	0.00134	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.0012	0.00133	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	0.0012	0.00133	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	0.00119	0.00131	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	0.00118	0.0013	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.00117	0.00129	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	0.00116	0.00128	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	0.00115	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	0.00115	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	0.00108	0.0012	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	0.00107	0.00118	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	0.00105	0.00116	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	0.00104	0.00115	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	0.00104	0.00115	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	0.00103	0.00114	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	0.00101	0.00112	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	0.000997	0.0011	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	0.000971	0.00107	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000957	0.00106	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	0.000956	0.00106	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	0.000936	0.00103	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	0.000936	0.00103	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	0.000886	0.000979	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD2—nicotine dependence	0.000876	0.000968	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	0.000875	0.000967	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	0.00087	0.000961	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	0.000861	0.000951	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD2—nicotine dependence	0.000858	0.000948	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	0.000849	0.000939	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	0.000823	0.00091	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	0.000789	0.000872	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	0.000765	0.000845	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	0.00075	0.000829	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	0.00071	0.000785	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	0.000677	0.000748	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	0.000632	0.000699	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	0.000622	0.000688	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	0.000553	0.000611	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	0.000514	0.000568	CbGpPWpGaD
